U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06941441) titled 'PAH Exercise Study' on April 15.
Brief Summary: Ten patients with PAH who are stable and eligible to initiate sotatercept therapy will participate in a 26 week study that consists of a 24-week intervention period where patients will receive complimentary sotatercept as prescribed, plus a tailored, progressive home exercise program with wrist-worn fitness tracker and oxygen saturation monitoring.
Study Start Date: April 15
Study Type: INTERVENTIONAL
Condition:
Pulmonary Arterial Hypertension (PAH)
Exercise Therapy
Intervention:
OTHER: Home exercise program
A tailored, progressive home exercise program with wrist-worn fitness ...